Targeting SARS-CoV-2 non-structural protein 13 via helicase-inhibitor-repurposing and non-structural protein 16 through pharmacophore-based screening
Md. Nazmus Samdani, Niaz Morshed, Rumman Reza, Muhammad Asaduzzaman, Abul Bashar Mir Md. Khademul Islam
Topics & Concepts
PharmacophoreRepurposingDrug repositioningSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)HelicaseVirologyVirtual screeningStructural proteinCoronavirus disease 2019 (COVID-19)Computational biologyDrug discoveryChemistryBiologyMedicineStereochemistryDrugPharmacologyBiochemistryVirusRNAInfectious disease (medical specialty)EcologyPathologyDiseaseGeneComputational Drug Discovery MethodsSARS-CoV-2 and COVID-19 Researchvaccines and immunoinformatics approaches